Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal (Q38051449)

27 August 2017

title

Bevacizumab for metastatic colorectal cancer: a NICE single technology appraisal (English)

1 reference

27 August 2017

1 reference

1 reference

metastatic colon cancer

1 reference

1 reference

2

1 reference

27 August 2017

3

Matt Stevenson

1 reference

27 August 2017

1

Sophie Whyte

1 reference

27 August 2017

publication date

1 December 2012

1 reference

27 August 2017

1 reference

27 August 2017

volume

30

1 reference

27 August 2017

issue

12

1 reference

27 August 2017

page(s)

1119-1132

1 reference

https://scigraph.springernature.com/pub.10.2165/11597210-000000000-00000

27 August 2017

exact match

0 references

cites work

Single technology appraisal at the UK National Institute for Health and clinical excellence: a source of evidence and analysis for decision making internationally

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Alitretinoin for severe chronic hand eczema: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Cetuximab for recurrent and/or metastatic squamous cell carcinoma of the head and neck: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Febuxostat for the management of hyperuricaemia in patients with gout: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Denosumab for the prevention of osteoporotic fractures in post-menopausal women: a NICE single technology appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing chemotherapy: a NICE single technology appraisal.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Dronedarone for the treatment of atrial fibrillation: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Dabigatran etexilate for the prevention of venous thromboembolism in patients undergoing elective hip or knee surgery: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Golimumab for the treatment of psoriatic arthritis: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Eltrombopag for the treatment of chronic immune or idiopathic thrombocytopenic purpura: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11 years: a NICE single technology appraisal

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Survival following recurrence in stage II and III colon cancer: findings from the ACCENT data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F11597210-000000000-00000

Pazopanib for the first-line treatment of patients with advanced and/or metastatic renal cell carcinoma : a NICE single technology appraisal

21 January 2018

1 reference

12 December 2020

Bivalirudin for the treatment of ST-segment elevation myocardial infarction: a NICE single technology appraisal

1 reference

12 December 2020

Golimumab for the treatment of ankylosing spondylitis: a NICE single technology appraisal

1 reference

12 December 2020

Retigabine for the adjunctive treatment of adults with partial-onset seizures in epilepsy with and without secondary generalization : a NICE single technology appraisal

1 reference

12 December 2020

Golimumab for the treatment of rheumatoid arthritis after the failure of previous disease-modifying antirheumatic drugs: a NICE single technology appraisal.

1 reference

12 December 2020

10.2165/11597210-000000000-00000

Identifiers

DOI

1 reference

Dimensions Publication ID

27 August 2017

1039607735

0 references

1 reference